Evaluation of MST-188 in Acute Lower Limb Ischemia

Acute Limb Ischemia Clinical Trial

Official title:
Evaluation of MST-188 in Acute Lower Limb Ischemia: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial Evaluating the Safety and Efficacy of MST-188 in Subjects With Acute Lower Limb Ischemia Receiving Catheter-Directed Recombinant Tissue Plasminogen Activator

Status Terminated

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02093468
Study type	Interventional
Source	Mast Therapeutics, Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	June 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03388021` - A Trial Comparing Routine Versus Selective Use of Completion Angiography After Surgical Thromboembolectomy in the Treatment of Acute Lower Limb Ischemia and Their Impacts on Limb Salvage Rates	N/A
Recruiting	`NCT06222658` - The Role of Pharmaco-mechanical Thrombectomy in Management of Acute Lower Extremity Arterial Ischemia	N/A
Recruiting	`NCT05372718` - Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial	Phase 3
Completed	`NCT05138679` - Evaluation of Acute Lower Limb Ischemia
Recruiting	`NCT05868161` - Pounce™ Thrombectomy System Retrospective Registry